Modified mRNA/lipid nanoparticle-based vaccines expressing respiratory syncytial virus F protein variants are immunogenic and protective in rodent models of RSV infection
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Modified mRNA/lipid nanoparticle-based vaccines expressing respiratory syncytial virus F protein variants are immunogenic and protective in rodent models of RSV infection
Authors
Keywords
-
Journal
npj Vaccines
Volume 5, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-02-14
DOI
10.1038/s41541-020-0163-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Characterization of HIV-1 nucleoside-modified mRNA vaccines in rabbits and rhesus macaques
- (2019) Norbert Pardi et al. Molecular Therapy-Nucleic Acids
- mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials
- (2019) Robert A. Feldman et al. VACCINE
- A proof of concept for structure-based vaccine design targeting RSV in humans
- (2019) Michelle C. Crank et al. SCIENCE
- The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates
- (2018) Natalie I Mazur et al. LANCET INFECTIOUS DISEASES
- A novel method for strict intranasal delivery of non-replicating RSV vaccines in cotton rats and non-human primates
- (2018) Michael P. Citron et al. VACCINE
- Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies
- (2018) Norbert Pardi et al. Nature Communications
- Development and application of a higher throughput RSV plaque assay by immunofluorescent imaging
- (2018) Zhiyun Wen et al. JOURNAL OF VIROLOGICAL METHODS
- Design and characterization of a fusion glycoprotein vaccine for Respiratory Syncytial Virus with improved stability
- (2018) Lan Zhang et al. VACCINE
- Modified mRNA-Based Vaccines Elicit Robust Immune Responses and Protect Guinea Pigs From Ebola Virus Disease
- (2017) Michelle Meyer et al. JOURNAL OF INFECTIOUS DISEASES
- A Single-Dose Recombinant Parainfluenza Virus 5-Vectored Vaccine Expressing Respiratory Syncytial Virus (RSV) F or G Protein Protected Cotton Rats and African Green Monkeys from RSV Challenge
- (2017) Dai Wang et al. JOURNAL OF VIROLOGY
- Characterization of Pre-F-GCN4t, a Modified Human Respiratory Syncytial Virus Fusion Protein Stabilized in a Noncleaved Prefusion Conformation
- (2017) Normand Blais et al. JOURNAL OF VIROLOGY
- Efficient Targeting and Activation of Antigen-Presenting Cells In Vivo after Modified mRNA Vaccine Administration in Rhesus Macaques
- (2017) Frank Liang et al. MOLECULAR THERAPY
- Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses
- (2017) Kapil Bahl et al. MOLECULAR THERAPY
- Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination
- (2017) Norbert Pardi et al. NATURE
- Inferior immunogenicity and efficacy of respiratory syncytial virus fusion protein-based subunit vaccine candidates in aged versus young mice
- (2017) Corinne Cayatte et al. PLoS One
- Structural, antigenic and immunogenic features of respiratory syncytial virus glycoproteins relevant for vaccine development
- (2017) José A. Melero et al. VACCINE
- Induction of Robust B Cell Responses after Influenza mRNA Vaccination Is Accompanied by Circulating Hemagglutinin-Specific ICOS+ PD-1+ CXCR3+ T Follicular Helper Cells
- (2017) Gustaf Lindgren et al. Frontiers in Immunology
- Preclinical evaluation of bacterially produced RSV-G protein vaccine: Strong protection against RSV challenge in cotton rat model
- (2017) Sandra Fuentes et al. Scientific Reports
- Iterative structure-based improvement of a fusion-glycoprotein vaccine against RSV
- (2016) M Gordon Joyce et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Stability Characterization of a Vaccine Antigen Based on the Respiratory Syncytial Virus Fusion Glycoprotein
- (2016) Jessica A. Flynn et al. PLoS One
- Iterative structure-based improvement of a fusion-glycoprotein vaccine against RSV
- (2016) M Gordon Joyce et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Brief History and Characterization of Enhanced Respiratory Syncytial Virus Disease
- (2015) Patricio L. Acosta et al. Clinical and Vaccine Immunology
- Prefusion F–specific antibodies determine the magnitude of RSV neutralizing activity in human sera
- (2015) Joan O. Ngwuta et al. Science Translational Medicine
- A highly stable prefusion RSV F vaccine derived from structural analysis of the fusion mechanism
- (2015) Anders Krarup et al. Nature Communications
- Characterization of a Prefusion-Specific Antibody That Recognizes a Quaternary, Cleavage-Dependent Epitope on the RSV Fusion Glycoprotein
- (2015) Morgan S. A. Gilman et al. PLoS Pathogens
- A Monomeric Uncleaved Respiratory Syncytial Virus F Antigen Retains Prefusion-Specific Neutralizing Epitopes
- (2014) K. A. Swanson et al. JOURNAL OF VIROLOGY
- Stabilization of Ostwald Ripening in Low Molecular Weight Amino Lipid Nanoparticles for Systemic Delivery of siRNA Therapeutics
- (2014) Marian E. Gindy et al. MOLECULAR PHARMACEUTICS
- Translational sciences approach to RSV vaccine development
- (2013) Vanessa Kurzweil et al. Expert Review of Vaccines
- Viral Shedding and Immune Responses to Respiratory Syncytial Virus Infection in Older Adults
- (2013) Edward E. Walsh et al. JOURNAL OF INFECTIOUS DISEASES
- Structure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing Antibody
- (2013) J. S. McLellan et al. SCIENCE
- Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus
- (2013) J. S. McLellan et al. SCIENCE
- Adults 65 Years Old and Older Have Reduced Numbers of Functional Memory T Cells to Respiratory Syncytial Virus Fusion Protein
- (2012) Anu Cherukuri et al. Clinical and Vaccine Immunology
- Role of Neutralizing Antibodies in Adults With Community-Acquired Pneumonia by Respiratory Syncytial Virus
- (2012) V. Luchsinger et al. CLINICAL INFECTIOUS DISEASES
- Respiratory Syncytial Virus Fusion Glycoprotein Expressed in Insect Cells Form Protein Nanoparticles That Induce Protective Immunity in Cotton Rats
- (2012) Gale Smith et al. PLoS One
- Nonviral delivery of self-amplifying RNA vaccines
- (2012) A. J. Geall et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Neutralizing antibodies against the preactive form of respiratory syncytial virus fusion protein offer unique possibilities for clinical intervention
- (2012) M. Magro et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Safety and immunogenicity of a Sf9 insect cell-derived respiratory syncytial virus fusion protein nanoparticle vaccine
- (2012) Gregory M. Glenn et al. VACCINE
- Structure of Respiratory Syncytial Virus Fusion Glycoprotein in the Postfusion Conformation Reveals Preservation of Neutralizing Epitopes
- (2011) J. S. McLellan et al. JOURNAL OF VIROLOGY
- Age related changes in T cell mediated immune response and effector memory to Respiratory Syncytial Virus (RSV) in healthy subjects
- (2010) Maria Grazia Cusi et al. Immunity & Ageing
- Risk Factors for Respiratory Failure Associated with Respiratory Syncytial Virus Infection in Adults
- (2009) Coley B. Duncan et al. JOURNAL OF INFECTIOUS DISEASES
- Generation of stable monoclonal antibody–producing B cell receptor–positive human memory B cells by genetic programming
- (2009) Mark J Kwakkenbos et al. NATURE MEDICINE
- Comparison of the Safety and Immunogenicity of 2 Respiratory Syncytial Virus (RSV) Vaccines— Nonadjuvanted Vaccine or Vaccine Adjuvanted with Alum—Given Concomitantly with Influenza Vaccine to High‐Risk Elderly Individuals
- (2008) Ann R. Falsey et al. JOURNAL OF INFECTIOUS DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now